Terms: = Breast cancer AND PBX1, P40424, 5087 AND Prognosis
5 results:
1. rs6426881 in the 3'-UTR of pbx1 is involved in breast and gastric cancers via altering the binding potential of miR-522-3p.
Mohammadi M; Salehzadeh A; Talesh Sasani S; Tarang A
Mol Biol Rep; 2021 Nov; 48(11):7405-7414. PubMed ID: 34655407
[TBL] [Abstract] [Full Text] [Related]
2. Intrafraction motion during partial breast irradiation depends on treatment time.
Hoekstra N; Habraken S; Swaak-Kragten A; Hoogeman M; Pignol JP
Radiother Oncol; 2021 Jun; 159():176-182. PubMed ID: 33798609
[TBL] [Abstract] [Full Text] [Related]
3. Coexpression of pbx1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative breast cancer via Data Mining.
Qiu Y; Lu G; Wu Y
J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
[TBL] [Abstract] [Full Text] [Related]
4. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
5. Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.
Rafiq S; Tapper W; Collins A; Khan S; Politopoulos I; Gerty S; Blomqvist C; Couch FJ; Nevanlinna H; Liu J; Eccles D
Cancer Res; 2013 Mar; 73(6):1883-91. PubMed ID: 23319801
[TBL] [Abstract] [Full Text] [Related]
